Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 226Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 30CURRAX

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 9107898

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2028-05-01

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 9486437

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-05-18

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 9861607

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-05-18

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 10238620

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-05-18

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 7915307

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-08-24

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 8513299

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2030-09-07

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 9572814

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-07-20

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 9572814

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-07-20

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 7915307

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2027-08-24

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXEPIN HYDROCHLORIDE

US Patent Number : 8513299

Drug Substance Claim :

Drug Product Claim :

Application Number : 22036

Patent Use Code : U-620

Delist Requested :

Patent Use Description : TREATMENT OF INSOMNIA

Patent Expiration Date : 2030-09-07

blank